comparemela.com

Latest Breaking News On - Academy professor seppo yl - Page 2 : comparemela.com

University of Eastern Finland researchers introduce a nasal COVID-19 vaccine

Rokote Laboratories Finland Ltd., a newly-founded academic spin-out based in Finland is working to develop and introduce to the markets a nasal spray vaccine against COVID. The vaccine is based on research carried out at the University of Helsinki and the University of Eastern Finland.

Eteläuomen läiSouth africaNorra savolaxUnited kingdomLandskapet birkalandSouth africanKari alitaloUniversity of helsinkiRokote laboratories finland ltdAcademy professor seppo ylUniversity of eastern finlandEastern finlandVirology kalle sakselaRokote laboratories finlandProfessor kalle sakselaProfessor kari alitalo

Finnish Researchers Introduce a Nasal COVID Vaccine

Finnish Researchers Introduce a Nasal COVID Vaccine
labmanager.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from labmanager.com Daily Mail and Mail on Sunday newspapers.

Eteläuomen läiSouth africaNorra savolaxUnited kingdomLandskapet birkalandSouth africanKari alitaloUniversity of helsinkiRokote laboratories finland ltdAi virtanen institute for molecular sciencesNational virus vector laboratoryAcademy professor seppo ylUniversity of eastern finlandFinnish researchers introduceMolecular sciencesLaboratories finland ltd

This coronavirus vaccine doesn t even need an injection

This coronavirus vaccine doesn’t even need an injection BGR 3/9/2021 © Provided by BGR Coronavirus Vaccine About a year ago, news of the first coronavirus vaccine candidates emerged, with researchers saying that the COVID-19 vaccines would take anywhere from 12 to 18 months to prepare. Hundreds of vaccine candidates appeared after that, and by the end of 2020, the world already had several front-runners. Some of them had even cleared clinical trials successfully. A few vaccine candidates failed along the way and were abandoned. Others finished Phase 3 trials in early 2021, and several vaccines are already in use in many countries. In fact, more than 312 million vaccine doses have been used worldwide, with over 186 million people having received at least one dose at the time of this writing. Pfizer/BioNTech, Moderna, AstraZeneca/Oxford, and Johnson & Johnson are some of the companies with drugs that are being used in North America, Europe, Israel, and other countries. Chin

United statesHong kongUnited kingdomSouth africaEteläuomen läiSouth africanAstrazeneca oxfordUniversity of helsinkiUniversity of helsinki professor virologyAcademy professor seppo ylUniversity of eastern finlandNorth americaLaboratories finlandEastern finlandHelsinki professorKalle saksela

New academic spin-out based in Finland introduces a nasal spray vaccine against COVID

New academic spin-out based in Finland introduces a nasal spray vaccine against COVID Mar 8 2021 Rokote Laboratories Finland Ltd., a newly-founded academic spin-out based in Finland is working to develop and introduce to the markets a nasal spray vaccine against COVID. The vaccine is based on research carried out at the University of Helsinki and the University of Eastern Finland. Image Credit: University of Eastern Finland The vaccine uses gene transfer technology developed at the University of Eastern Finland by Academy Professor Seppo Ylä-Herttuala s research group, and the technology has already been successfully used in several clinical trials using gene therapy to treat cardiovascular diseases and cancer.

Eteläuomen läiSouth africaNorra savolaxUnited kingdomLandskapet birkalandSouth africanKari alitaloSeppo ylEmily hendersonUniversity of helsinkiAcademy professorRokote laboratories finland ltdAcademy professor seppo ylUniversity of eastern finlandLaboratories finland ltdEastern finland

University of Helsinki and University of Eastern Finland shareholders in a Finnish COVID vaccine company

Date Time University of Helsinki and University of Eastern Finland shareholders in a Finnish COVID vaccine company Rokote Laboratories Finland Ltd., is a newly-founded, Finnish academic spin-out working to develop and introduce to the markets a nasal spray vaccine against COVID. The vaccine is based on research carried out at the University of Helsinki and the University of Eastern Finland. The founders and board members of the company are the vaccine developers Academy Professor Seppo Ylä-Herttuala from the University of Eastern Finland, Professor Kalle Saksela and Professor Kari Alitalo from the University of Helsinki, and Mr Pasi Kemppainen, MSc (Techn.). The University of Helsinki and the University of Eastern Finland are also co-founders of, and shareholders in, the company.

Norra savolaxUnited kingdomSouth africaEteläuomen läiLandskapet birkalandSouth africanKari alitaloUniversity of helsinkiRokote laboratories finland ltdAcademy professor seppo ylUniversity of eastern finlandAcademy professor ylUniversity of helsinki paula eerolaAcademy of finlandRector of the university eastern finlandEastern finland

vimarsana © 2020. All Rights Reserved.